Klaus Rieneck Selected Research

Klaus Rieneck Research Topics

6	Neoplasms (Cancer) 01/2013 - 02/2003
2	Anemia 10/2021 - 10/2021
2	Hypersensitivity (Allergy) 01/2003 - 01/2003
1	Severe combined immunodeficiency due to adenosine deaminase deficiency 11/2020
1	Transfusion Reaction 10/2019
1	Sideroblastic Anemia 12/2015
1	Hemolysis 10/2015
1	Fetal Diseases (Embryopathy) 01/2015
1	Sickle Cell Anemia (Hemoglobin S Disease) 11/2013
1	Inflammation (Inflammations) 07/2006
1	Stomach Diseases 07/2006
1	Achlorhydria (Hypochlorhydria) 07/2006
1	Metaplasia 07/2006
1	Arthritis (Polyarthritis) 09/2004
1	Rheumatoid Arthritis 05/2004
1	Heart Failure 02/2004
1	Necrosis 02/2004
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2003

3	AntibodiesIBA 10/2021 - 01/2015
2	AntigensIBA 10/2021 - 10/2019
2	Proteins (Proteins, Gene)FDA Link 11/2020 - 12/2015
2	Blood Group Antigens (Blood Groups)IBA 10/2015 - 11/2013
2	InterferonsIBA 07/2006 - 02/2004
2	Spironolactone (Aldactone)FDA LinkGeneric 09/2004 - 02/2004
2	CytokinesIBA 09/2004 - 02/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2004 - 02/2004
1	IronIBA 12/2015
1	SulfurIBA 12/2015
1	Heme (Haem)IBA 12/2015
1	DNA (Deoxyribonucleic Acid)IBA 11/2013
1	Proton Pump InhibitorsIBA 07/2006
1	AcidsIBA 07/2006
1	GastrinsIBA 07/2006
1	ErbB Receptors (EGF Receptor)IBA 10/2005
1	Interferon-gamma (Interferon, gamma)IBA 09/2004
1	RNA (Ribonucleic Acid)IBA 05/2004
1	Rheumatoid FactorIBA 05/2004
1	ImmunosorbentsIBA 02/2004
1	EnzymesIBA 02/2004
1	InterleukinsIBA 02/2004
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2004
1	Messenger RNA (mRNA)IBA 02/2004
1	Mineralocorticoid Receptor AntagonistsIBA 02/2004
1	OligonucleotidesIBA 04/2003
1	Interleukin-2 (IL2)IBA 02/2003
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2003
1	Immunoglobulin E (IgE)IBA 01/2003
1	Interleukin-4 (Interleukin 4)IBA 01/2003
1	Immunoglobulin G (IgG)IBA 01/2003
1	AllergensIBA 01/2003

2	Intraperitoneal Injections 12/2012 - 09/2008
1	Intrauterine Blood Transfusion 10/2021
1	Immunotherapy 01/2013